David Rosen – ABUS history
- Issuer:
- ARBUTUS BIOPHARMA CORP
- Quarters tracked:
- 13 (Q4 2022 → Q2 2026)
- Current shares:
- 7,532,937
- Current value:
- $36.16M
- Peak shares:
- 7,532,937 (Q2 2026)
- Overall change:
- +117%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 7,532,937 | $36.16M | $4.80 | +906,548 | +14% |
| Q1 2026 | 6,626,389 | $29.82M | $4.50 | +5,051,013 | +321% |
| Q4 2025 | 1,575,376 | $7.58M | $4.81 | 0 | 0% |
| Q3 2025 | 1,575,376 | $7.15M | $4.54 | 0 | 0% |
| Q2 2025 | 1,575,376 | $4.87M | $3.09 | -105,714 | -6% |
| Q1 2025 | 1,681,090 | $5.87M | $3.49 | 0 | 0% |
| Q4 2024 | 1,681,090 | $5.50M | $3.27 | 0 | 0% |
| Q3 2024 | 1,681,090 | $6.47M | $3.85 | 0 | 0% |
| Q2 2024 | 1,681,090 | $5.20M | $3.09 | +1,681,090 | +100% |
| Q3 2023 | SOLD | — | — | -3,395,855 | -100% |
| Q2 2023 | 3,395,855 | $7.81M | $2.30 | -799,217 | -19% |
| Q1 2023 | 4,195,072 | $12.71M | $3.03 | +728,791 | +21% |
| Q4 2022 | 3,466,281 | $8.08M | $2.33 | — | NEW |